SCHEDULE 13G: Citigroup Entities Disclose 4.3% Passive Stake in Nextcure, Inc.

Citigroup Global Markets Inc. and its affiliates have disclosed a passive beneficial ownership of 4.3% of Nextcure, Inc.'s common stock as of March 31, 2025.

Summary

• Citigroup Global Markets Inc., Citigroup Financial Products Inc., Citigroup Global Markets Holdings Inc., and Citigroup Inc. have jointly filed a Schedule 13G.
• As of March 31, 2025, these entities collectively beneficially own 1,205,193 shares of Nextcure, Inc. common stock.
• This represents 4.3% of Nextcure, Inc.'s outstanding common stock.
• The filing indicates that the shares are held with shared voting and shared dispositive power, and no sole voting or sole dispositive power.
• The ownership is stated to be in the ordinary course of business and not for the purpose of changing or influencing control of Nextcure, Inc.

Sentiment

Score: 5

Explanation: The document is a factual disclosure of passive beneficial ownership by a large financial institution. It does not contain information that would significantly alter the perceived value or future prospects of Nextcure, Inc. beyond the routine nature of institutional holdings.

Positives

• The disclosure indicates significant institutional ownership by a major financial entity, Citigroup, which can be viewed as a standard investment by a large financial institution.
• The filing is a routine compliance disclosure, indicating transparency regarding beneficial ownership.

Future Outlook

NA

Management Comments

• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11."

Industry Context

This filing represents a routine disclosure by a major financial institution, Citigroup, regarding its passive investment in Nextcure, Inc. Such disclosures are common for large banks and brokerage firms that hold securities for various clients or through their trading and derivatives activities. It does not indicate a strategic move within the broader industry but rather a compliance requirement for significant, passive shareholdings.

Stakeholder Impact

• Shareholders: Provides transparency regarding significant institutional ownership in Nextcure, Inc.
• Regulatory Authorities: Fulfills SEC disclosure requirements for beneficial ownership.

Key Dates

Keywords

Nextcure Inc., Citigroup, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, SEC Filing, Passive Investment, Financial Services